Recursion Pharmaceuticals (RXRX) Interest Coverage Ratio (2020 - 2026)
Recursion Pharmaceuticals (RXRX) posted Interest Coverage Ratio of 29.77 for Q1 2026, down 9.36% on a QoQ basis from 27.23 in Q4 2025, and up 18.08% year-over-year from 25.21 in Q1 2025.
Recursion Pharmaceuticals (RXRX) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Recursion Pharmaceuticals' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 29.77 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 18.08% year-over-year to 29.77 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21.93 (up 26.11% YoY) and the FY2025 annual result came in at 0.97, up 5.21% from the prior year.
- Interest Coverage Ratio was 29.77 for Q1 2026 at Recursion Pharmaceuticals, down from 27.23 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 6.82 in Q2 2025 and bottomed at 4813.31 in Q3 2022.
- A 5-year average of 1467.6 and a median of 36.35 in 2025 frame the typical range for Interest Coverage Ratio.
- Peak annual rise in Interest Coverage Ratio reached 99.6% in 2022, while the deepest fall reached 28790.39% in 2022.
- Recursion Pharmaceuticals' Interest Coverage Ratio stood at 17.14 in 2022, then jumped by 41.05% to 10.1 in 2023, then plunged by 38.54% to 14.0 in 2024, then sank by 94.5% to 27.23 in 2025, then slipped by 9.36% to 29.77 in 2026.
- Business Quant data shows RXRX's Interest Coverage Ratio at 29.77 in Q1 2026, 27.23 in Q4 2025, and 8.51 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Recursion Pharmaceuticals | 1.59 Bn | 933.22 Mn | -6.02 Mn | -29.77 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.77 |
| Dec 31, 2025 | -27.23 |
| Sep 30, 2025 | -8.51 |
| Jun 30, 2025 | -6.82 |
| Mar 31, 2025 | -36.35 |
| Dec 31, 2024 | -14.00 |
| Sep 30, 2024 | -177.86 |
| Jun 30, 2024 | -255.19 |
| Mar 31, 2024 | -24.36 |
| Dec 31, 2023 | -10.10 |
| Sep 30, 2023 | -3,982.00 |
| Jun 30, 2023 | -3,142.88 |
| Mar 31, 2023 | -3,677.11 |
| Dec 31, 2022 | -17.14 |
| Sep 30, 2022 | -4,813.31 |
| Jun 30, 2022 | -4,727.93 |
| Mar 31, 2022 | -3,998.64 |
| Dec 31, 2021 | -4,330.67 |
| Sep 30, 2021 | -210.92 |
| Jun 30, 2021 | -16.37 |